Sood Ajit, Kaur Kirandeep, Singh Arshdeep, Midha Vandana, Mahajan Ramit, Bansal Namita, Mehta Varun, Singh Dharmatma
Department of Gastroenterology, Dayanand Medical College and Hospital, Ludhiana, India.
Department of Pharmacology, Dayanand Medical College and Hospital, Ludhiana, India.
Intest Res. 2021 Jul;19(3):282-290. doi: 10.5217/ir.2020.00010. Epub 2020 Aug 18.
BACKGROUND/AIMS: Inflammatory bowel disease (IBD), including ulcerative colitis (UC) and Crohn's disease (CD), is increasingly being reported from India and other Asian countries. This study looks into the changing trends of IBD at a tertiary care center in north India over last two decades.
Retrospective analysis of a prospectively maintained database of patients diagnosed with IBD between January 1991 and December 2015 was conducted. The study period was divided into five times cohorts (1991-1995, 1996-2000, 2001-2005, 2006-2010, 2011-2015).
During the study period, 2,467 patients (UC [n = 2,137, 86.6%], CD [n = 330, 13.3%], mean age 38.5 ± 13.3 years; 55.9% males) were registered. The proportion of patients with CD increased (ratio of UC to CD declined from 15.7:1 to 4:1). The mean age at diagnosis decreased for UC (45.7 ± 12.1 years in 1991-1995 vs. 37.6 ± 13.0 years in 2011-2015; P= 0.001) and remained consistent for CD (41.3 ± 13.6 years in 1996-2000 vs. 41.3 ± 16.9 years in 2011-2015, P= 0.86). Patients with proctitis in UC and isolated ileal disease in CD increased over the study period (P= 0.001 and P= 0.007, respectively). Inflammatory CD increased (P= 0.009) whereas stricturing CD decreased (P= 0.01) across all cohorts. There was a trend towards less severe presentation of both UC and CD. The use of thiopurines (P= 0.02) and biologics increased (P= 0.001) with no significant change in trends for requirements of surgery (P= 0.9).
Increasing prevalence of CD, younger age at diagnosis, diagnosis at an earlier and milder stage, greater use of thiopurines and biologics were observed.
背景/目的:炎症性肠病(IBD),包括溃疡性结肠炎(UC)和克罗恩病(CD),在印度和其他亚洲国家的报道日益增多。本研究调查了印度北部一家三级医疗中心过去二十年IBD的变化趋势。
对1991年1月至2015年12月期间前瞻性维护的IBD确诊患者数据库进行回顾性分析。研究期分为五个时间段队列(1991 - 1995年、1996 - 2000年、2001 - 2005年、2006 - 2010年、2011 - 2015年)。
在研究期间,登记了2467例患者(UC [n = 2137,86.6%],CD [n = 330,13.3%],平均年龄38.5±13.3岁;55.9%为男性)。CD患者的比例增加(UC与CD的比例从15.7:1降至4:1)。UC的诊断平均年龄下降(1991 - 1995年为45.7±12.1岁,2011 - 2015年为37.6±13.0岁;P = 0.001),而CD保持一致(1996 - 2000年为41.3±13.6岁,2011 - 2015年为41.3±16.9岁,P = 0.86)。在研究期间,UC中的直肠炎患者和CD中的孤立性回肠疾病患者增加(分别为P = 0.001和P = 0.007)。在所有队列中,炎症性CD增加(P = 0.009)而狭窄性CD减少(P = 0.01)。UC和CD的病情表现均有减轻的趋势。硫唑嘌呤的使用增加(P = 0.02),生物制剂的使用增加(P = 0.001),而手术需求趋势无显著变化(P = 0.9)。
观察到CD患病率增加、诊断年龄降低、诊断处于更早和更轻阶段、硫唑嘌呤和生物制剂使用增加。